These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7518023)

  • 1. [Early diagnosis of prostatic cancer: state of the art].
    Martínez de Hurtado J; Chéchile G; Villavicencio H
    Med Clin (Barc); 1994 May; 102(18):708-14. PubMed ID: 7518023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of prostate cancer].
    Kaprin AD; Anan'ev AP; Amosov FR; Gafanov RA
    Vopr Onkol; 1999; 45(1):20-5. PubMed ID: 10941360
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on secondary prevention of prostate cancer from the Canadian Task Force on the Periodic Health Examination.
    Feightner JW
    Can J Oncol; 1994 Nov; 4 Suppl 1():80-1. PubMed ID: 8853497
    [No Abstract]   [Full Text] [Related]  

  • 4. [PSA: a new prostatic marker. A help or an added factor of confusion?].
    Huber PR; Wisard M; Schmid HP
    Ann Urol (Paris); 1994; 28(4):235-7. PubMed ID: 7526773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the prostate: pitfalls in diagnosis.
    Vera Donoso CD; Jimenez Cruz JF
    Arch Ital Urol Androl; 1993 Dec; 65(6):647-51. PubMed ID: 7508791
    [No Abstract]   [Full Text] [Related]  

  • 6. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on urology--prostatic cancer. 2--Diagnosis and assessment of prostatic cancer.
    Ravery V; Boccon-Gibod L
    Eur J Surg Oncol; 1995 Aug; 21(4):419-21. PubMed ID: 7545138
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].
    Voisin E; Piaton E; Rivain T; Duco F
    Prog Urol; 1992 Dec; 2(6):973-9. PubMed ID: 1284556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
    Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
    Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
    Kaulen H
    Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and histopathological characteristics of nonpalpable prostatic carcinoma].
    Landmann C
    Strahlenther Onkol; 1995 Mar; 171(3):174-5. PubMed ID: 7535953
    [No Abstract]   [Full Text] [Related]  

  • 12. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 13. Is digital screening for prostatic cancer effective?
    Louria DB
    Bull N Y Acad Med; 1992 Nov; 68(4):470-5. PubMed ID: 1283361
    [No Abstract]   [Full Text] [Related]  

  • 14. [The prostate-specific antigen in the early recognition of prostate carcinoma].
    Wolff JM; Jakse G
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1508-14. PubMed ID: 8983908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current role of echography, of PSA and of PSAD in the diagnosis of prostatic carcinoma].
    Pizzoccaro M; Valtorta A; Cappellano F; Sironi D; Catanzaro F
    Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):77-80. PubMed ID: 7534169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with transrectal ultrasonic studies in patients with prostatic tumors].
    Romics I; Rüssel C; Bach D
    Orv Hetil; 1990 Feb; 131(7):359-62. PubMed ID: 2183150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
    Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
    Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate-specific antigen].
    Huland H
    Dtsch Med Wochenschr; 1996 May; 121(21):710. PubMed ID: 8646979
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations from the BC Office of Health Technology Assessment.
    Bassett K
    Can J Oncol; 1994 Nov; 4 Suppl 1():86-8; discussion 89-95. PubMed ID: 8853499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening with PSA, DRE and TRUS.
    Cusan L
    Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.